Feinstein Institute Scientist Recognized for Innovative CLL Research

Feinstein Institute Scientist Recognized for Innovative CLL Research

Feinstein Institute for Medical Research Instructor Shih-Shih Chen, PhD, is continuing the Institute's tradition of innovating the diagnosis and treatment of chronic lymphocytic leukemia (CLL) through the recognition of her research that identifies a potential new therapy target for CLL.

The award was presented at the recent International Workshop on Chronic Lymphocytic Leukemia (iwCLL) for her abstract titled: "IL-4R – IL-4 axis Disruption by Ibrutinib Therapy Contributes to the Greater Vulnerability of U-CLL Clones to Loss of Microenvironmental Input."

These latest findings join the contributions made by Feinstein Institute Professors Kanti R. Rai, MD, and Nicholas Chiorazzi, MD, who have long been at the forefront of diagnosis and care of patients with CLL.

prnewswire.com/news-release...

oldestnewest

    You may also like...